Navigation Links
Misleading media coverage of medicine
Date:11/26/2008

Media coverage of clinical trials does not contain the elements readers require to make informed decisions. A comparison of the coverage received by pharmaceutical and herbal remedy trials, reported in the open access journal BMC Medicine, has revealed that it is rarely possible for the lay public to assess the credibility of the described research.

Tania Bubela from the University of Alberta, Canada, led a team of researchers who investigated 201 pharmaceutical and 352 herbal remedy newspaper articles, and studied the 48 pharmaceutical and 57 herbal remedy clinical trials that the stories referred to. For both complementary and mainstream medicine, stories under-reported risk and lacked any disclosure of trial funding or scientists' conflicts of interest. Bubela said, "There were significant errors of omission of basic information such as dose, sample size and methods for randomized clinical trials. In addition, there is an under-reporting of risks, especially in the context of herbal remedies".

The main theme of almost all articles on pharmaceutical clinical trials was the trial itself. This contrasted with articles on herbal remedy clinical trials where 63.6% focused on the trial and the other third focused on other issues such as the myriad uses for any particular herb. The main benefit cited in almost all articles was improved health or treatment options. The study found that the media is overly reliant on narratives from satisfied patients, researchers, clinicians and patient groups - without disclosing these people's financial ties to industry and conflicts of interest.

According to Bubela, "The study is not all bad news for the media. Slowly they are beginning to report on the welcome trend of evidence based clinical trials for complementary and alternative medicine (CAM), including herbal remedies. Unfortunately, the media still rely for their sources on high quality medical journals, which are more likely to report n
'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-707-94804
BioMed Central
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Hospital Quality Info on Web Can Be Misleading
2. Full-Service Community Hospitals Blast Misleading Letter to Candidates From Limited-Service Hospitals
3. Workers With No Healthcare Protecting Kaiser Facilities, Security Contractor May Be Misleading Californias Largest Healthcare Provider
4. Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign
5. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
6. AUDIO from Medialink and Kelloggs: Whats in Your Water?
7. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
8. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
9. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
10. Weiner Public News First Media Team at National Press Club 5K
11. VIDEO from Medialink and General Motors: On and Off the Track
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... Forest Laboratories,Inc. (NYSE: FRX ), an ... its Fiscal 2008 Fourth Quarter,financial results before the ... Later that day, at 10:00 AM EDT, Forest ... President and Chief Operating Officer and Frank,Perier, Senior ...
... ALB ) will hold its quarterly conference call to ... ET., This call is being webcast by Thomson/CCBN and ... in the Investor,Information section., To listen ... In # 800-591-6942 International Dial In ...
... 2008 Caring,Advocates will host a free, interactive ... to demonstrate a new Internet-based technology: a low ... implement Living Wills,and Durable Powers of Attorney for ... preferences with healthcare,professionals to establish effective, much-needed plans., ...
... higher levels of estrogen replacement proved more dangerous , , MONDAY, ... uncover the benefits and risks of hormone therapy for women, ... woman takes may determine whether it helps or harms her. ... of estrogen were safer, while moderate and high doses increased ...
... Poston is a pioneer in the use of robotics for ... Center (BMC) as chief of cardiac surgery. With his ... hospitals across the country, and the only hospital in Boston, ... advanced treatment available for coronary artery disease (the most common ...
... New York Hospital Upgrades Three X-Ray Rooms from Film to IDC ... ... April 7 /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the ... that Saratoga Hospital in Saratoga,Springs, New York has purchased IDC,s X2200, ...
Other Medicine News:Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings 2Health News:Albemarle Corporation's First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET 2Health News:'Interview by Internet' Can Decrease Greatest End-of-Life Fears: It Facilitates Creating Effective Advance Directives, Living Wills 2Health News:HRT Dosing May Determine Risks, Benefits 2Health News:HRT Dosing May Determine Risks, Benefits 3Health News:Robot-assisted minimally-invasive CABG surgery 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 3
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... New data on Eloxatin(R), Taxotere(R) and on three ... presented at the 43rd,annual ASCO meeting, BRIDGEWATER, N.J., ... a total of 375 abstracts,indicative of its oncology ... of the American Society of Clinical Oncology,(ASCO) in ...
... , AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007--Introgen,Therapeutics, Inc. (NASDAQ:INGN) ... clinical benefit of its lead product,Advexin in a ... known as,Li-Fraumeni Syndrome (LFS), a genetic disorder characterized ... This is the,first reported treatment of Li-Fraumeni tumors ...
Other Medicine Technology:Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
... Katena Products, Inc. is ... company dedicated exclusively to ophthalmic ... products to over 7,000 customers ... through a global network of ...
... management of diabetes in order to maintain tight ... effective way to reduce or even prevent diabetes-related ... improving a diabetes patients quality of life, however, ... have been the guiding factors in the development ...
... intended for detecting trends and tracking patterns ... and older) and children/adolescents (aged 7 to ... use of the G2 Biographer with their ... supplement, not replace, conventional blood glucose monitoring. ...
... is a mini glaucoma ... of filtration surgery for patients ... trabeculectomy, the shunt reduces the ... humor from the anterior chamber ...
Medicine Products: